CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)
Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%
Conmed pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Conmed's pe ratio was 27.4× on Nov 11, 2026, against 21.2× a year earlier. Over the last 5 years it ranged from 11.6× to 440.5×, with a median of 30.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 27.4× | +7.6 |
| 2025 | Dec 31, 2025 | 19.8× | +3.5 |
| 2024 | Dec 31, 2024 | 16.3× | −42.6 |
| 2023 | Dec 29, 2023 | 58.9× | +12.4 |
| 2022 | Jul 29, 2022 | 46.5× | −24.4 |
| 2021 | Dec 31, 2021 | 70.9× | −3.5 |
| 2020 | Jul 31, 2020 | 74.4× | −37.5 |
| 2019 | Dec 31, 2019 | 111.8× | +86.4 |
| 2018 | Dec 31, 2018 | 25.5× | −65.5 |
| 2017 | Dec 29, 2017 | 91.0× | +12.1 |
| 2016 | Dec 30, 2016 | 78.9× | +43.1 |
| 2015 | Dec 31, 2015 | 35.8× | −4.7 |
| 2014 | Dec 31, 2014 | 40.5× | +7.6 |
| 2013 | Dec 31, 2013 | 32.9× | −182.1 |
| 2012 | Dec 31, 2012 | 215.0× | +192.5 |
| 2011 | Dec 30, 2011 | 22.5× | −40.4 |
| 2010 | Dec 31, 2010 | 62.9× | – |
See a number that looks wrong?